Rockland Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Rockland Trust's EW Position: Q3 2026 in Review
Rockland Trust increased its Edwards Lifesciences (EW) stake by 5.5% in Q3 2026, buying an estimated $17.2K and bringing the position to 3,749 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #268.
Rockland Trust first reported a position in EW in Q3 2021 and has held it in 21 quarters since. The position peaked at $899K in Q4 2021. 1,332 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Rockland Trust held 3,749 shares of Edwards Lifesciences worth $324K as of Q3 2026.
- Rockland Trust bought 194 Edwards Lifesciences shares in Q3 2026, an estimated $17.2K.
- Edwards Lifesciences made up 0.01% of Rockland Trust's portfolio in Q3 2026, its #268 holding.
- Rockland Trust first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 21 quarters since.
- Rockland Trust's Edwards Lifesciences position peaked at $899K in Q4 2021.
- 1,332 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Rockland Trust's 13F filing for Q3 2026, filed 5 Oct 2026.